New Delhi: Ashish Dhawan, a leading investor called ‘Warren Buffet of India’, had invested in two companies in his portfolio for 10 years, but after such a long time he has trimmed his stake in the firms. Among these stocks is a global pharma giant and the other is a laminates manufacturer exporting to 120 countries. The companies are Glenmark Pharmaceuticals and Greenlam Industries. So why did the investor distance themselves from these stocks ?

Glenmark Pharmaceuticals

Glenmark Pharmaceuticals, which has a market cap of around Rs 51,318 crore, was part of Dhawan’s portfolio since December 2019. By June 2025, he held a of 1.24%, but according to the filing of September 2025, it fell below 1%.

Glenmark’s sales increased from Rs 10,641 crore in FY20 to Rs 13,322 crore in FY25, regis

See Full Page